Ivana Đuran
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ivana Đuran has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
Bojana Ljubicic
Faculty of Medicine, University of Novi Sad, Novi Sad, SRB
2 shared publications- Danilo Medin
Faculty of Medicine, University of Novi Sad, 21137 Novi Sad, Serbia
2 shared publications - Nikola Glogonjac
Clinic for Nephrology and Clinical Immunology, University Clinical Center of Vojvodina, 21137 Novi Sad, Serbia
2 shared publications - Sonja Golubovic
Faculty of Medicine, University of Novi Sad
2 shared publications Violeta Knezevic
Faculty of Medicine, University of Novi Sad, Novi Sad, SRB
2 shared publicationsAna Kalinić
Faculty of Medicine University of Novi Sad Novi Sad Serbia
1 shared publication
Latest Publications
- Open Access
- 1 July 2026
- Published by MDPI AG in Psychiatry International
- Vol. 7 (4) , 142
The Dominant Role of Depression over Cognitive Impairment in Determining Quality of Life Among Hemodialysis Patients: Evidence from Mediation Analysis
Background and Aims: Cognitive impairment (CI) and depression are frequent comorbidities in chronic hemodialysis (HD) patients with substantial impact on health-related quality of life (HRQoL). This study examined their prevalence, predictors, and independent associations with HRQoL. Methods: A cross-sectional study enrolled 70 adult maintenance HD patients. Cognitive functioning was assessed with the Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA); depressive symptoms with the Beck Depression Inventory (BDI); and HRQoL with the Kidney Disease Quality of Life instrument (KDQOL-SF). Logistic regression, multiple linear regression, and mediation analysis were applied. Results: CI (MoCA ≤ 24) was present in 54.3% of patients; clinically significant depressive symptoms (BDI ≥ 14) were present in 44.4%. BDI was not correlated with MoCA (p = 0.656) or MMSE (p = 0.880), confirming independence of the two dimensions in cross-section. Older age (OR = 1.106, p = 0.001) and male sex (OR = 4.523, p = 0.022) were independent predictors of CI. BDI significantly correlated with 15 of 19 KDQOL domains and was the dominant predictor across 10 domains in multiple linear regression (Adj. R2 up to 0.358). MoCA correlated with only two KDQOL domains. Mediation analysis confirmed that MoCA does not mediate the BDI–HRQoL relationship (indirect effect: −0.004, 95% bootstrap CI: −0.106 to +0.097). Conclusions: CI and depression are highly prevalent and clinically distinct dimensions in HD patients, though subtle longitudinal interactions cannot be excluded. Depression is the dominant determinant of impaired HRQoL, acting through a direct, cognitively independent pathway, and represents the primary modifiable target for improving quality of life in this population.
- 1 July 2026
- Published by MDPI AG in Psychiatry International
- Vol. 7 (4) , 142
Open AccessThe Dominant Role of Depression over Cognitive Impairment in Determining Quality of Life Among Hemodialysis Patients: Evidence from Mediation Analysis
Background and Aims: Cognitive impairment (CI) and depression are frequent comorbidities in chronic hemodialysis (HD) patients with substantial impact on health-related quality of life (HRQoL). This study examined their prevalence, predictors, and independent associations with HRQoL. Methods: A cross-sectional study enrolled 70 adult maintenance HD patients. Cognitive functioning was assessed with the Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA); depressive symptoms with the Beck Depression Inventory (BDI); and HRQoL with the Kidney Disease Quality of Life instrument (KDQOL-SF). Logistic regression, multiple linear regression, and mediation analysis were applied. Results: CI (MoCA ≤ 24) was present in 54.3% of patients; clinically significant depressive symptoms (BDI ≥ 14) were present in 44.4%. BDI was not correlated with MoCA (p = 0.656) or MMSE (p = 0.880), confirming independence of the two dimensions in cross-section. Older age (OR = 1.106, p = 0.001) and male sex (OR = 4.523, p = 0.022) were independent predictors of CI. BDI significantly correlated with 15 of 19 KDQOL domains and was the dominant predictor across 10 domains in multiple linear regression (Adj. R2 up to 0.358). MoCA correlated with only two KDQOL domains. Mediation analysis confirmed that MoCA does not mediate the BDI–HRQoL relationship (indirect effect: −0.004, 95% bootstrap CI: −0.106 to +0.097). Conclusions: CI and depression are highly prevalent and clinically distinct dimensions in HD patients, though subtle longitudinal interactions cannot be excluded. Depression is the dominant determinant of impaired HRQoL, acting through a direct, cognitively independent pathway, and represents the primary modifiable target for improving quality of life in this population.
- Open Access
- 18 June 2026
- Published by Association of Basic Medical Sciences of FBIH in Biomolecules and Biomedicine
- Vol. 26 (11) , 2360-2371
Coronary artery calcium and multiparametric cardiovascular risk assessment in non-dialysis chronic kidney disease
Cardiovascular disease is a leading cause of mortality in chronic kidney disease (CKD), but whether impaired renal function independently increases coronary artery calcium (CAC) burden in patients with comparable cardiovascular referral indications remains uncertain. This retrospective cross-sectional study included 206 adults who underwent coronary computed tomography angiography (CCTA) with simultaneous Agatston scoring at the Institute for Cardiovascular Diseases of Vojvodina between 2020 and 2025. Patients were classified as having eGFR-defined non-dialysis CKD stages 3–5 (n=110; estimated glomerular filtration rate [eGFR] ≤59 mL/min/1.73 m²) or preserved renal function (n=96; eGFR ≥60 mL/min/1.73 m²). Both groups were drawn from the same cardiovascular referral population. The primary outcome was total Agatston score, while secondary analyses included Agatston severity categories, significant vessel-level stenosis, calcified coronary segment count, eGFR–Agatston correlation, and predictors of severe CAC. Total Agatston scores did not differ significantly between CKD and control groups (median 248.5 vs. 198.0; p=0.240), and severe calcification was similarly frequent (40.0% vs. 41.6%). Vessel-level stenosis, calcified segment distribution, and the eGFR–Agatston correlation were also non-significant. In multivariable logistic regression adjusted for age, sex, hypertension, diabetes, and prior coronary artery bypass grafting (CABG), CKD was not independently associated with severe CAC. However, CKD patients showed a markedly more adverse cardiovascular phenotype, including more hypertension, angina, peripheral arterial disease, prior CABG, lower left ventricular ejection fraction (LVEF), higher right ventricular systolic pressure (RVSP), and more severe valvular disease. These findings suggest that CAC scoring alone does not capture the multidimensional cardiovascular burden of non-dialysis CKD and should be integrated with echocardiographic and systemic vascular assessment in high-risk referral populations.
- 18 June 2026
- Published by Association of Basic Medical Sciences of FBIH in Biomolecules and Biomedicine
- Vol. 26 (11) , 2360-2371
Open AccessCoronary artery calcium and multiparametric cardiovascular risk assessment in non-dialysis chronic kidney disease
Cardiovascular disease is a leading cause of mortality in chronic kidney disease (CKD), but whether impaired renal function independently increases coronary artery calcium (CAC) burden in patients with comparable cardiovascular referral indications remains uncertain. This retrospective cross-sectional study included 206 adults who underwent coronary computed tomography angiography (CCTA) with simultaneous Agatston scoring at the Institute for Cardiovascular Diseases of Vojvodina between 2020 and 2025. Patients were classified as having eGFR-defined non-dialysis CKD stages 3–5 (n=110; estimated glomerular filtration rate [eGFR] ≤59 mL/min/1.73 m²) or preserved renal function (n=96; eGFR ≥60 mL/min/1.73 m²). Both groups were drawn from the same cardiovascular referral population. The primary outcome was total Agatston score, while secondary analyses included Agatston severity categories, significant vessel-level stenosis, calcified coronary segment count, eGFR–Agatston correlation, and predictors of severe CAC. Total Agatston scores did not differ significantly between CKD and control groups (median 248.5 vs. 198.0; p=0.240), and severe calcification was similarly frequent (40.0% vs. 41.6%). Vessel-level stenosis, calcified segment distribution, and the eGFR–Agatston correlation were also non-significant. In multivariable logistic regression adjusted for age, sex, hypertension, diabetes, and prior coronary artery bypass grafting (CABG), CKD was not independently associated with severe CAC. However, CKD patients showed a markedly more adverse cardiovascular phenotype, including more hypertension, angina, peripheral arterial disease, prior CABG, lower left ventricular ejection fraction (LVEF), higher right ventricular systolic pressure (RVSP), and more severe valvular disease. These findings suggest that CAC scoring alone does not capture the multidimensional cardiovascular burden of non-dialysis CKD and should be integrated with echocardiographic and systemic vascular assessment in high-risk referral populations.
- Open Access
Clinical and Echocardiographic Predictors of Major Adverse Cardiovascular Events in ANCA-Associated Vasculitis
Background and Objectives: Cardiovascular disease is the leading cause of mortality in patients with ANCA-associated vasculitis (AAV) after the first year post-diagnosis. This study investigated relationships between traditional risk factors, echocardiographic findings, disease activity, and major adverse cardiovascular events (MACE) in AAV patients. Aim: This retrospective single-center study aimed to evaluate the impact of traditional cardiovascular risk factors and echocardiographic parameters on the occurrence of MACE in patients with AAV. Materials and Methods: This study included adult patients with AAV who were evaluated between 2020 and 2025. Data collected included demographics, cardiovascular risk factors, Birmingham Vasculitis Activity Score version 3 (BVASv3), laboratory parameters, immunosuppressive therapy, and transthoracic echocardiography (TTE) findings. MACE was defined as myocardial infarction, stroke, revascularization, cardiovascular hospitalization, or cardiovascular death. Results: The cohort comprised 32 females (61.5%) and 20 males (38.5%), with a mean age of 62.4 ± 12.4 years. MACE occurred in 38.5% of patients. Male gender (p = 0.002), overweight (p = 0.016), hyperlipidemia (p = 0.003), and prior cardiovascular disease (p = 0.002) were significantly associated with MACE in univariate analyses. Patients with MACE had larger left atrial anteroposterior dimensions on the parasternal long-axis view (median 3.9 vs. 3.3 cm, p = 0.002) and lower left ventricular ejection fraction assessed by the modified biplane Simpson’s method (median 53% vs. 60%, p = 0.002). Valvular dysfunction was not associated with MACE in a statistically significant manner. Disease activity markers (BVASv3 and CRP) showed no significant correlation with cardiovascular events or echocardiographic parameters. Conclusions: Our results demonstrate that traditional cardiovascular risk factors are stronger determinants of MACE in AAV patients than disease-specific parameters. Cardiac structural changes, including left atrial dilation and decreased left ventricular ejection fraction, were significantly associated with cardiovascular outcomes. These findings underscore the importance of integrating systematic cardiovascular risk assessment and aggressive risk factor modification into standard AAV management protocols.
Open AccessClinical and Echocardiographic Predictors of Major Adverse Cardiovascular Events in ANCA-Associated Vasculitis
Background and Objectives: Cardiovascular disease is the leading cause of mortality in patients with ANCA-associated vasculitis (AAV) after the first year post-diagnosis. This study investigated relationships between traditional risk factors, echocardiographic findings, disease activity, and major adverse cardiovascular events (MACE) in AAV patients. Aim: This retrospective single-center study aimed to evaluate the impact of traditional cardiovascular risk factors and echocardiographic parameters on the occurrence of MACE in patients with AAV. Materials and Methods: This study included adult patients with AAV who were evaluated between 2020 and 2025. Data collected included demographics, cardiovascular risk factors, Birmingham Vasculitis Activity Score version 3 (BVASv3), laboratory parameters, immunosuppressive therapy, and transthoracic echocardiography (TTE) findings. MACE was defined as myocardial infarction, stroke, revascularization, cardiovascular hospitalization, or cardiovascular death. Results: The cohort comprised 32 females (61.5%) and 20 males (38.5%), with a mean age of 62.4 ± 12.4 years. MACE occurred in 38.5% of patients. Male gender (p = 0.002), overweight (p = 0.016), hyperlipidemia (p = 0.003), and prior cardiovascular disease (p = 0.002) were significantly associated with MACE in univariate analyses. Patients with MACE had larger left atrial anteroposterior dimensions on the parasternal long-axis view (median 3.9 vs. 3.3 cm, p = 0.002) and lower left ventricular ejection fraction assessed by the modified biplane Simpson’s method (median 53% vs. 60%, p = 0.002). Valvular dysfunction was not associated with MACE in a statistically significant manner. Disease activity markers (BVASv3 and CRP) showed no significant correlation with cardiovascular events or echocardiographic parameters. Conclusions: Our results demonstrate that traditional cardiovascular risk factors are stronger determinants of MACE in AAV patients than disease-specific parameters. Cardiac structural changes, including left atrial dilation and decreased left ventricular ejection fraction, were significantly associated with cardiovascular outcomes. These findings underscore the importance of integrating systematic cardiovascular risk assessment and aggressive risk factor modification into standard AAV management protocols.
- Open Access
- 26 November 2025
- Published by Springer Nature in Cureus
- Vol. 17 (11) , e97844
Primary Sjögren’s Syndrome Presenting With Hypokalemic Rhabdomyolysis, Distal Renal Tubular Acidosis, and Fulminant Necrotizing Vasculitis: A Case Report
Primary Sjögren’s syndrome (pSS) is a systemic autoimmune disease characterized by exocrine gland dysfunction and heterogeneous extraglandular manifestations. Renal involvement, most frequently distal renal tubular acidosis (dRTA), may present with severe metabolic disturbances. Rhabdomyolysis due to hypokalemia and systemic vasculitis are uncommon but potentially life-threatening complications. We report a 36-year-old woman who presented with fever, profuse diarrhea, progressive proximal muscle weakness, and a 10-kg weight loss. Laboratory evaluation revealed profound hypokalemia, hyperchloremic non-anion gap metabolic acidosis consistent with dRTA, and rhabdomyolysis with creatine phosphokinase (CPK) of 42,000 U/L. Electromyoneurography (EMNG) confirmed inflammatory myopathy, while autoimmune serology was positive for antinuclear antibody (ANA), anti-Ro52, anti-SSA, and anti-proliferating cell nuclear antigen (PCNA) with marked hypocomplementemia. Despite supportive therapy, she developed an acute abdomen. Emergency laparotomy revealed perforated ischemic colitis and gangrenous cholecystitis. Histopathology confirmed necrotizing vasculitis of small- and medium-sized arteries. Treatment included continuous renal replacement therapy (RRT) with cytokine hemoadsorption. After surgical stabilization and histopathological confirmation of necrotizing vasculitis, immunosuppressive therapy was initiated according to the European League Against Rheumatism (EULAR) and Kidney Disease: Improving Global Outcomes (KDIGO) recommendations for the management of severe systemic vasculitis with visceral involvement. The patient received intravenous pulse cyclophosphamide (CYC) at a dose of 800 mg (corresponding to a total induction dose of approximately 2.5-3 g (as recommended for remission induction), combined with high-dose methylprednisolone with gradual tapering. Supportive measures included intravenous hydration, Mesna uroprotection, and antiemetic prophylaxis. The patient showed significant clinical improvement, normalization of electrolyte and laboratory parameters, and functional recovery within two weeks. This case underscores two severe extraglandular phenotypes of pSS: dRTA-induced hypokalemic rhabdomyolysis and fulminant systemic necrotizing vasculitis. Both are rarely reported and carry high morbidity and mortality. Recognition of hypokalemia as a potential trigger for rhabdomyolysis and vigilance for vasculitic complications are crucial for timely diagnosis. Multidisciplinary management, including nephrology, immunology, surgery, and aggressive immunosuppression, proved life-saving. pSS may present with atypical and catastrophic extraglandular involvement. Physicians should maintain a high index of suspicion when encountering metabolic disturbances with multisystem features. Early recognition and coordinated intervention can significantly improve outcomes.
- 26 November 2025
- Published by Springer Nature in Cureus
- Vol. 17 (11) , e97844
Open AccessPrimary Sjögren’s Syndrome Presenting With Hypokalemic Rhabdomyolysis, Distal Renal Tubular Acidosis, and Fulminant Necrotizing Vasculitis: A Case Report
Primary Sjögren’s syndrome (pSS) is a systemic autoimmune disease characterized by exocrine gland dysfunction and heterogeneous extraglandular manifestations. Renal involvement, most frequently distal renal tubular acidosis (dRTA), may present with severe metabolic disturbances. Rhabdomyolysis due to hypokalemia and systemic vasculitis are uncommon but potentially life-threatening complications. We report a 36-year-old woman who presented with fever, profuse diarrhea, progressive proximal muscle weakness, and a 10-kg weight loss. Laboratory evaluation revealed profound hypokalemia, hyperchloremic non-anion gap metabolic acidosis consistent with dRTA, and rhabdomyolysis with creatine phosphokinase (CPK) of 42,000 U/L. Electromyoneurography (EMNG) confirmed inflammatory myopathy, while autoimmune serology was positive for antinuclear antibody (ANA), anti-Ro52, anti-SSA, and anti-proliferating cell nuclear antigen (PCNA) with marked hypocomplementemia. Despite supportive therapy, she developed an acute abdomen. Emergency laparotomy revealed perforated ischemic colitis and gangrenous cholecystitis. Histopathology confirmed necrotizing vasculitis of small- and medium-sized arteries. Treatment included continuous renal replacement therapy (RRT) with cytokine hemoadsorption. After surgical stabilization and histopathological confirmation of necrotizing vasculitis, immunosuppressive therapy was initiated according to the European League Against Rheumatism (EULAR) and Kidney Disease: Improving Global Outcomes (KDIGO) recommendations for the management of severe systemic vasculitis with visceral involvement. The patient received intravenous pulse cyclophosphamide (CYC) at a dose of 800 mg (corresponding to a total induction dose of approximately 2.5-3 g (as recommended for remission induction), combined with high-dose methylprednisolone with gradual tapering. Supportive measures included intravenous hydration, Mesna uroprotection, and antiemetic prophylaxis. The patient showed significant clinical improvement, normalization of electrolyte and laboratory parameters, and functional recovery within two weeks. This case underscores two severe extraglandular phenotypes of pSS: dRTA-induced hypokalemic rhabdomyolysis and fulminant systemic necrotizing vasculitis. Both are rarely reported and carry high morbidity and mortality. Recognition of hypokalemia as a potential trigger for rhabdomyolysis and vigilance for vasculitic complications are crucial for timely diagnosis. Multidisciplinary management, including nephrology, immunology, surgery, and aggressive immunosuppression, proved life-saving. pSS may present with atypical and catastrophic extraglandular involvement. Physicians should maintain a high index of suspicion when encountering metabolic disturbances with multisystem features. Early recognition and coordinated intervention can significantly improve outcomes.
- Open Access
- 29 September 2025
- Published by Springer Nature in Cureus
- Vol. 17 (9) , e93472
Anti-PL-12 and Interstitial Lung Disease as the First Signs of Antisynthetase Syndrome in Patients With Previously Diagnosed Systemic Lupus Erythematosus
Antisynthetase syndrome (ASTS) is an infrequent autoimmune condition marked by chronic inflammation and the presence of autoantibodies targeting aminoacyl-tRNA synthetases. Clinically, it often manifests through a constellation of features, including inflammatory arthritis, myositis, Raynaud's phenomenon, hyperkeratotic skin changes (mechanic's hands), and interstitial lung disease (ILD). Among these, ILD is the most significant in terms of prognosis, as it contributes to elevated rates of morbidity and mortality, surpassing those seen in other idiopathic inflammatory myopathies. We report the clinical course of a 56-year-old woman with a prior diagnosis of systemic lupus erythematosus (SLE) established in 2019, based on the 2017 European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) classification criteria. She was admitted to the Institute for Pulmonary Diseases of Vojvodina (IPBV) in Sremska Kamenica, Serbia, due to respiratory symptoms suggestive of ILD. Although ILD is an uncommon manifestation in SLE, the patient was assessed for the potential coexistence of other connective tissue diseases, such as systemic sclerosis (SSc) and inflammatory myopathies. Laboratory testing demonstrated a strong antinuclear antibody (ANA) reactivity on Hep-2 cells and low anti-double-stranded DNA (anti-dsDNA) levels (<10 IU/ml). Extended myositis panel testing revealed marked positivity for anti-PL-12 and anti-Ro-52 antibodies. Given the presence of pre-existing ILD and clinical signs of arthritis and proximal muscle weakness, alongside the identification of anti-tRNA synthetases antibodies, a diagnosis of ASTS was established. Immunosuppressive treatment was intensified by increasing the glucocorticoid (GC) dosage and introducing intravenous cyclophosphamide (CYC, 1 g). The patient demonstrated a favorable clinical and biochemical response to this regimen.
- 29 September 2025
- Published by Springer Nature in Cureus
- Vol. 17 (9) , e93472
Open AccessAnti-PL-12 and Interstitial Lung Disease as the First Signs of Antisynthetase Syndrome in Patients With Previously Diagnosed Systemic Lupus Erythematosus
Antisynthetase syndrome (ASTS) is an infrequent autoimmune condition marked by chronic inflammation and the presence of autoantibodies targeting aminoacyl-tRNA synthetases. Clinically, it often manifests through a constellation of features, including inflammatory arthritis, myositis, Raynaud's phenomenon, hyperkeratotic skin changes (mechanic's hands), and interstitial lung disease (ILD). Among these, ILD is the most significant in terms of prognosis, as it contributes to elevated rates of morbidity and mortality, surpassing those seen in other idiopathic inflammatory myopathies. We report the clinical course of a 56-year-old woman with a prior diagnosis of systemic lupus erythematosus (SLE) established in 2019, based on the 2017 European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) classification criteria. She was admitted to the Institute for Pulmonary Diseases of Vojvodina (IPBV) in Sremska Kamenica, Serbia, due to respiratory symptoms suggestive of ILD. Although ILD is an uncommon manifestation in SLE, the patient was assessed for the potential coexistence of other connective tissue diseases, such as systemic sclerosis (SSc) and inflammatory myopathies. Laboratory testing demonstrated a strong antinuclear antibody (ANA) reactivity on Hep-2 cells and low anti-double-stranded DNA (anti-dsDNA) levels (<10 IU/ml). Extended myositis panel testing revealed marked positivity for anti-PL-12 and anti-Ro-52 antibodies. Given the presence of pre-existing ILD and clinical signs of arthritis and proximal muscle weakness, alongside the identification of anti-tRNA synthetases antibodies, a diagnosis of ASTS was established. Immunosuppressive treatment was intensified by increasing the glucocorticoid (GC) dosage and introducing intravenous cyclophosphamide (CYC, 1 g). The patient demonstrated a favorable clinical and biochemical response to this regimen.
- Open Access
- 1 January 2025
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Hospital Pharmacology - International Multidisciplinary Journal
- Vol. 12 (3) , 1703-1709
Comparison of CT scans with and without contrast in the characterization of adrenal gland adenomas
Introduction: With the increased use of diagnostic procedures such as computed tomography (CT), the detection of asymptomatic adrenal lesions demonstrates a growing trend. Accurately distinguishing these lesions is essential for guiding future diagnostic and treatment approaches. Aim: This study aimed to investigate whether it is possible to determine the adenomatous characteristics of adrenal tumors on non-contrast CT scans. Material and Method: A retrospective observational study was conducted at the University Clinical Center of Vojvodina (UKCV), involving 43 patients who underwent CT imaging following the adrenal protocol. The key parameters examined were: sex, age, antero-posterior (AP) and latero-lateral diameter (LL) of the adenoma, non-contrast density, absolute (APW) and relative (RPW) washout. Results: Our study has shown a statistically significant negative correlation between non-contrast density and RPW (p<0.001), as well as significant positive correlation between APW and RPW (p=0.007). The non-contrast density demonstrated a statistically significant positive correlation with the AP diameter of the adenoma (p=0.035). Conclusion: Our research shows that when using unenhanced CT imaging, a non-contrast density significantly below 10 Hounsfield units (HU) and a lesion diameter under 40 mm strongly suggest an adrenal gland adenoma, potentially allowing for diagnosis without multiple scans or contrast.
- 1 January 2025
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Hospital Pharmacology - International Multidisciplinary Journal
- Vol. 12 (3) , 1703-1709
Open AccessComparison of CT scans with and without contrast in the characterization of adrenal gland adenomas
Introduction: With the increased use of diagnostic procedures such as computed tomography (CT), the detection of asymptomatic adrenal lesions demonstrates a growing trend. Accurately distinguishing these lesions is essential for guiding future diagnostic and treatment approaches. Aim: This study aimed to investigate whether it is possible to determine the adenomatous characteristics of adrenal tumors on non-contrast CT scans. Material and Method: A retrospective observational study was conducted at the University Clinical Center of Vojvodina (UKCV), involving 43 patients who underwent CT imaging following the adrenal protocol. The key parameters examined were: sex, age, antero-posterior (AP) and latero-lateral diameter (LL) of the adenoma, non-contrast density, absolute (APW) and relative (RPW) washout. Results: Our study has shown a statistically significant negative correlation between non-contrast density and RPW (p<0.001), as well as significant positive correlation between APW and RPW (p=0.007). The non-contrast density demonstrated a statistically significant positive correlation with the AP diameter of the adenoma (p=0.035). Conclusion: Our research shows that when using unenhanced CT imaging, a non-contrast density significantly below 10 Hounsfield units (HU) and a lesion diameter under 40 mm strongly suggest an adrenal gland adenoma, potentially allowing for diagnosis without multiple scans or contrast.
- Open Access
- 1 January 2024
- Published by National Library of Serbia in Medicinski Pregled
- Vol. 77 (1-2) , 63-66
Rare case of unileaflet mitral valve diagnosed by computed tomography
Introduction. Congenital malformations of the mitral valve encompass a broad spectrum of lesions, with an incidence of approximately 0.4% among patients with congenital heart diseases. Case Report. A 45-year-old female was admitted to our institution due to a confirmed mitral valve defect identified via echocardiographic examination. She presented with leg swelling and rapid fatigue. Her medical history includes systemic lupus erythematosus. Upon admission, she was in cardiopulmonary decompensation, with a systolic murmur detected in the mitral valve area, radiating towards the axilla. Transesophageal echocardiographic revealed severe mitral stenosis with moderate regurgitation, without clear visualization of the two cusps. Cardiac computed tomography confirmed a voluminous anterior mitral cusp and a hypoplastic posterior cusp, observed in diastole as a crescent-shaped, characteristic of a unicuspid mitral valve. Follow-up echocardiographic showed progression of mitral regurgitation with circumferential pericardial effusion, necessitating pericardiocentesis. Due to further hemodynamic instability, urgent surgical mitral valve replacement was indicated. The surgery proceeded without complications, but the immediate period was marked by exacerbation of renal impairment, requiring hemodiafiltration on several occasions. Following cardiological stabilization, the patient was transferred to the Nephrology Clinic for further management of renal insufficiency and systemic lupus. Conclusion. It is crucial to emphasize the significance of a multidisciplinary approach for each patient, with particular emphasis on detailed imaging diagnostics to definitively establish a congenital heart disease diagnosis.
- 1 January 2024
- Published by National Library of Serbia in Medicinski Pregled
- Vol. 77 (1-2) , 63-66
Open AccessRare case of unileaflet mitral valve diagnosed by computed tomography
Introduction. Congenital malformations of the mitral valve encompass a broad spectrum of lesions, with an incidence of approximately 0.4% among patients with congenital heart diseases. Case Report. A 45-year-old female was admitted to our institution due to a confirmed mitral valve defect identified via echocardiographic examination. She presented with leg swelling and rapid fatigue. Her medical history includes systemic lupus erythematosus. Upon admission, she was in cardiopulmonary decompensation, with a systolic murmur detected in the mitral valve area, radiating towards the axilla. Transesophageal echocardiographic revealed severe mitral stenosis with moderate regurgitation, without clear visualization of the two cusps. Cardiac computed tomography confirmed a voluminous anterior mitral cusp and a hypoplastic posterior cusp, observed in diastole as a crescent-shaped, characteristic of a unicuspid mitral valve. Follow-up echocardiographic showed progression of mitral regurgitation with circumferential pericardial effusion, necessitating pericardiocentesis. Due to further hemodynamic instability, urgent surgical mitral valve replacement was indicated. The surgery proceeded without complications, but the immediate period was marked by exacerbation of renal impairment, requiring hemodiafiltration on several occasions. Following cardiological stabilization, the patient was transferred to the Nephrology Clinic for further management of renal insufficiency and systemic lupus. Conclusion. It is crucial to emphasize the significance of a multidisciplinary approach for each patient, with particular emphasis on detailed imaging diagnostics to definitively establish a congenital heart disease diagnosis.